# An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients

> **NCT05089435** · PHASE4 · UNKNOWN · sponsor: **Sigknow Biomedical Co., Ltd.** · enrollment: 500 (estimated)

## Conditions studied

- Atrial Fibrillation
- Embolic Stroke of Undetermined Source

## Interventions

- **DEVICE:** EZYPRO® ECG Recorder

## Key facts

- **NCT ID:** NCT05089435
- **Lead sponsor:** Sigknow Biomedical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-28
- **Primary completion:** 2023-03
- **Final completion:** 2023-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05089435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05089435, "An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05089435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*